These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12923223)

  • 1. Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?
    Foulon V; Asselberghs S; Geens W; Mannaerts GP; Casteels M; Van Veldhoven PP
    J Lipid Res; 2003 Dec; 44(12):2349-55. PubMed ID: 12923223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.
    Mukherji M; Kershaw NJ; Schofield CJ; Wierzbicki AS; Lloyd MD
    Chem Biol; 2002 May; 9(5):597-605. PubMed ID: 12031666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.
    Mukherji M; Chien W; Kershaw NJ; Clifton IJ; Schofield CJ; Wierzbicki AS; Lloyd MD
    Hum Mol Genet; 2001 Sep; 10(18):1971-82. PubMed ID: 11555634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular mechanisms of Refsum disease.
    McDonough MA; Kavanagh KL; Butler D; Searls T; Oppermann U; Schofield CJ
    J Biol Chem; 2005 Dec; 280(49):41101-10. PubMed ID: 16186124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytanoyl-CoA hydroxylase: recognition of 3-methyl-branched acyl-coAs and requirement for GTP or ATP and Mg(2+) in addition to its known hydroxylation cofactors.
    Croes K; Foulon V; Casteels M; Van Veldhoven PP; Mannaerts GP
    J Lipid Res; 2000 Apr; 41(4):629-36. PubMed ID: 10744784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A.
    Kershaw NJ; Mukherji M; MacKinnon CH; Claridge TD; Odell B; Wierzbicki AS; Lloyd MD; Schofield CJ
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2545-8. PubMed ID: 11549466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of phytanic acid oxidation in Refsum disease fibroblasts from patients with mutations in the phytanoyl-CoA hydroxylase gene.
    Chahal A; Khan M; Pai SG; Barbosa E; Singh I
    FEBS Lett; 1998 Jun; 429(1):119-22. PubMed ID: 9657395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PAHX, a Refsum disease gene.
    Mihalik SJ; Morrell JC; Kim D; Sacksteder KA; Watkins PA; Gould SJ
    Nat Genet; 1997 Oct; 17(2):185-9. PubMed ID: 9326939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
    Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
    J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
    Pahan K; Khan M; Singh I
    J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a brain specific protein that associates with a refsum disease gene product, phytanoyl-CoA alpha-hydroxylase.
    Lee ZH; Kim H; Ahn KY; Seo KH; Kim JK; Bae CS; Kim KK
    Brain Res Mol Brain Res; 2000 Feb; 75(2):237-47. PubMed ID: 10686344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain pyruvate and 2-oxoglutarate dehydrogenase complexes are mitochondrial targets of the CoA ester of the Refsum disease marker phytanic acid.
    Bunik VI; Raddatz G; Wanders RJ; Reiser G
    FEBS Lett; 2006 Jun; 580(14):3551-7. PubMed ID: 16737698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase.
    Watkins PA; Howard AE; Gould SJ; Avigan J; Mihalik SJ
    J Lipid Res; 1996 Nov; 37(11):2288-95. PubMed ID: 8978480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-hydroxylation of phytanic acid in rat liver microsomes: implications for Refsum disease.
    Komen JC; Duran M; Wanders RJ
    J Lipid Res; 2004 Jul; 45(7):1341-6. PubMed ID: 15102880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene.
    Jansen GA; Ofman R; Ferdinandusse S; Ijlst L; Muijsers AO; Skjeldal OH; Stokke O; Jakobs C; Besley GT; Wraith JE; Wanders RJ
    Nat Genet; 1997 Oct; 17(2):190-3. PubMed ID: 9326940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism.
    Lloyd MD; Mukherji M; Kershaw NJ; Chien W; Wierzbicki AS; Schofield CJ
    Adv Exp Med Biol; 2003; 544():303-4. PubMed ID: 14713244
    [No Abstract]   [Full Text] [Related]  

  • 17. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes.
    Watkins PA; Howard AE; Mihalik SJ
    Biochim Biophys Acta; 1994 Oct; 1214(3):288-94. PubMed ID: 7918611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7).
    Jansen GA; Waterham HR; Wanders RJ
    Hum Mutat; 2004 Mar; 23(3):209-18. PubMed ID: 14974078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
    Wierzbicki AS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
    Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
    J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.